Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07544251 · ClinicalTrials.gov registry record · Phase 4
Comparing Sarecycline and Doxycycline Effects on the Skin and Gut Bacteria in Acne.
A Phase 4 study, sponsored by Integrative Skin Science and Research.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
NCT07544251 is a Phase 4 study that is actively recruiting participants, run by Integrative Skin Science and Research. The registered enrollment target is 30 participants.
The verdict
NCT07544251, a Phase 4 study, is actively recruiting participants, sponsored by Integrative Skin Science and Research.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
Study Summary
This study is being done to help better understand how the gut and skin bacteria of the body change when people with acne are treated with Sarecycline or Doxycycline. The bacteria in the gut and on the skin will be studied to see how each treatment may affect them and whether they change the profile of the bacteria that is present.
Interventions
- DRUG Doxycycline
- DRUG Sarecycline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-04-20 |
| Est. Completion | 2027-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07544251
The ClinicalTrials.gov registry entry for NCT07544251 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Integrative Skin Science and Research, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Doxycycline is the first listed.
NCT07544251 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07544251 about?
NCT07544251 is a clinical study titled "Comparing Sarecycline and Doxycycline Effects on the Skin and Gut Bacteria in Acne.". This study is being done to help better understand how the gut and skin bacteria of the body change when people with acne are treated with Sarecycline or Doxycycline. The bacteria in the gut and on the skin will be studied to see how each treatment may affect them and whether they change the profile...
What is the current status of trial NCT07544251?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2026-04-20. Estimated completion is 2027-06.
What interventions are being tested in trial NCT07544251?
The interventions under investigation include: Doxycycline (DRUG), Sarecycline (DRUG).
Who is sponsoring clinical trial NCT07544251?
This trial is sponsored by Integrative Skin Science and Research, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.